BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10976413)

  • 21. Do younger women with elevated basal follicular stimulating hormone levels undergoing gonadotropin-stimulated intrauterine insemination cycles represent compromised reproductive outcomes?
    Devranoğlu B; Özdamar Ö; Köle E; Eken MK; Bozdağ H; Doğer E
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():141-5. PubMed ID: 26930042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IVF performance of women who have fluctuating early follicular FSH levels.
    Lass A; Gerrard A; Abusheikha N; Akagbosu F; Brinsden P
    J Assist Reprod Genet; 2000 Nov; 17(10):566-73. PubMed ID: 11209537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome.
    Creus M; Peñarrubia J; Fábregues F; Vidal E; Carmona F; Casamitjana R; Vanrell JA; Balasch J
    Hum Reprod; 2000 Nov; 15(11):2341-6. PubMed ID: 11056129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro fertilization outcome according to age and follicle-stimulating hormone levels on cycle day 3.
    Bassil S; Godin PA; Gillerot S; Verougstraete JC; Donnez J
    J Assist Reprod Genet; 1999 May; 16(5):236-41. PubMed ID: 10335469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.
    Toner JP; Philput CB; Jones GS; Muasher SJ
    Fertil Steril; 1991 Apr; 55(4):784-91. PubMed ID: 1901282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.
    Balasch J; Fábregues F; Creus M; Peñarrubia J; Vidal E; Carmona F; Puerto B; Vanrell JA
    J Assist Reprod Genet; 2000 Jan; 17(1):20-7. PubMed ID: 10754779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
    Wang S; Zhang Y; Mensah V; Huber WJ; Huang YT; Alvero R
    J Ovarian Res; 2018 Jul; 11(1):60. PubMed ID: 30012195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization.
    Iwase A; Ando H; Kuno K; Mizutani S
    Obstet Gynecol; 2005 Mar; 105(3):645-52. PubMed ID: 15738039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels.
    Martin JS; Nisker JA; Tummon IS; Daniel SA; Auckland JL; Feyles V
    Fertil Steril; 1996 Jun; 65(6):1238-40. PubMed ID: 8641506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian stimulation and intrauterine insemination in women aged 40 years or more.
    Wiser A; Shalom-Paz E; Reinblatt SL; Son WY; Das M; Tulandi T; Holzer H
    Reprod Biomed Online; 2012 Feb; 24(2):170-3. PubMed ID: 22197126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
    Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
    Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH; Weghofer A; Gleicher N
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thorough sonographic oocyte retrieval during in vitro fertilization produces results similar to ovarian wedge resection in patients with clomiphene citrate-resistant polycystic ovarian syndrome.
    Branigan EF; Estes A; Walker K; Rothgeb J
    Am J Obstet Gynecol; 2006 Jun; 194(6):1696-700; discussion 1700-1. PubMed ID: 16731088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clomiphene citrate challenge test for the prediction of poor ovarian response and nonpregnancy in patients undergoing in vitro fertilization: a systematic review.
    Hendriks DJ; Mol BW; Bancsi LF; te Velde ER; Broekmans FJ
    Fertil Steril; 2006 Oct; 86(4):807-18. PubMed ID: 16962116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.
    Ochin H; Ma X; Wang L; Li X; Song J; Meng Y; Shen J; Cui YG; Liu J
    J Ovarian Res; 2018 May; 11(1):37. PubMed ID: 29728130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F-G-test) allows effective drug regimen selection for IVF.
    Ranieri DM; Phophong P; Khadum I; Meo F; Davis C; Serhal P
    Hum Reprod; 2001 Apr; 16(4):673-5. PubMed ID: 11278216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients.
    Bishop LA; Richter KS; Patounakis G; Andriani L; Moon K; Devine K
    Fertil Steril; 2017 Dec; 108(6):980-987. PubMed ID: 29202975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.